Recent Quotes

My Watchlist

Indicators

Transmedics Group Inc (NQ: TMDX )

84.27 +1.86 (+2.26%)

Streaming Delayed Price Updated: 1:54 PM EST, Nov 4, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	719,675
Open	82.03
Bid (Size)	84.19 (8)
Ask (Size)	84.34 (1)
Prev. Close	82.40
Today's Range	81.74 - 84.97
52wk Range	40.01 - 177.37
Shares Outstanding	32,553,650
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Top Growth Stock Down 50% to Buy After Its Recent Pullback

Today 7:15 EST

TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.

Via The Motley Fool

Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review

November 01, 2024

The major indexes declined, but haven't fallen apart.

Via Investor's Business Daily

Performance

YTD	+9.72%	+9.72%
1 Month	-39.36%	-39.36%
3 Month	-43.24%	-43.24%
6 Month	-36.48%	-36.48%
1 Year	+109.67%	+109.67%

More News

3 Stocks Well Below 52-Week Highs With Strong Growth Projections

November 01, 2024

Via MarketBeat

This Is What Whales Are Betting On TransMedics Gr

October 30, 2024

Via Benzinga

Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock

October 29, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,000 Today

October 28, 2024

Via Benzinga

TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

October 30, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results

October 29, 2024

Via Benzinga

Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries

October 29, 2024

Via Benzinga

Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views

October 29, 2024

Via Benzinga

What to Expect from TransMedics Gr's Earnings

October 25, 2024

Via Benzinga

How Is The Market Feeling About TransMedics Gr?

October 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session

October 29, 2024

Via Benzinga

These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results

October 29, 2024

Via Benzinga

TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat?

October 29, 2024

Via The Motley Fool

TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

October 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

October 29, 2024

Via Benzinga

Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

October 29, 2024

Via Benzinga

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket

October 29, 2024

Via Benzinga

INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm

October 28, 2024

From DiCello Levitt LLP

Via GlobeNewswire

TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers

October 28, 2024

Via Investor's Business Daily

TransMedics Group Stock Sinks On Q3 Earnings: The Details

October 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session

October 28, 2024

Via Benzinga

2 Growth Stocks to Buy Now That Are Flying Under the Radar

October 25, 2024

Via The Motley Fool

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4

October 22, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.